RxDoctor Payments Data

Brian Rizzo, DO

Facial Plastic Surgery · Phoenix, AZNPI 1720067390

Payments from drug & device makers

What this record shows

This record is dominated by other: $37,607 of the $46,710 with a category attached, or 80.5%. Olympus America Inc. accounts for 80.5% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $39,107, more than ten times the $118 reported in 2019.

$46,710in general payments, 2019–2025

Across 144 payments — averaging $324.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus America Inc.$38K
  • Acclarent, Inc$5K
  • Integra Lifesciences Corporation$1K
  • Medical Device Business Services, Inc.$797
  • GSK$544
  • Stryker$365
  • plus $2K from 20 others

What the payments were for

  • Travel & lodging$5,66412%
  • Food & beverage$3,3777%
  • Education$570%
  • Gifts$40%
  • Other$37,60781%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few facial plastic surgery providers in Arizonato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$407,817
Medicare patients
696
Services billed
9,549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab15$55,789
Sucralfate92$9,841
Famotidine462$8,209
Azelastine Hcl157$5,743
Omeprazole244$4,521
Esomeprazole Magnesium82$4,330
Ipratropium Bromide139$3,015
Tobramycin-DexamethasoneTobramycin/Dexamethasone21$2,582
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort39$2,203
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth17$2,163
Fluocinolone Acetonide Oil29$1,547
Glycopyrrolate37$1,212
Mupirocin150$1,125
Montelukast Sodium59$896
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav70$866

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →